Thailand and Indonesia unveil plans to develop molnupiravir Covid-19 pill
Thailand's health minister said yesterday the country planned to develop the anti-viral pill molnupiravir to combat Covid-19 infections amid rising infections driven by the Omicron variant.
The molnupiravir Covid-19 treatment pill for adult patients at risk of developing severe illness was jointly developed by US-based Merck & Co Inc and Ridgeback Biotherapeutics...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable